Funding propels company’s proprietary platform consisting of Generative AI models and large-scale datasets purpose-built for designing and validating novel proteins, opening new frontiers in therapeutics and industrial applications
...
Dr. Alex Colville joins forces with Laura Deming to lead investments in longevity science moonshots, after deploying $100M fund last year while at Stanford
age1, a venture capital firm catalyzing ...
Launch fueled by syndicate of blue-chip investors co-led by Qiming Venture Partners USA and venBio Partners
Company’s proprietary end-to-end Encompass™ platform designs enhancement-targeting chimeric (ENTAC™) molecules
Founding team ...
Startups are creating diets tailored to patients’ medical needs, betting that specially-designed foods can work as powerful weapons against disease.
Interest among venture capitalists in the medical potential of food ...
Just a decade after Crispr was invented, the first drug to make use of the revolutionary gene-editing technology will be with regulators by the end of the year, with ...
